Management of heartburn not responding to proton pump inhibitors

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Gut

• Publication date

  2009-01-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/gut.2007.145581PMID 19136523
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Barrett’s Oesophagus

  2012cited by this paper
• Proton-Pump Inhibitor Therapy in Patients with Gastro-Oesophageal Reflux Disease

  2012cited by this paper
• Oesophageal afferent pathway sensitivity in non‐erosive reflux disease

  2008cited by this paper
• Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups.

  2008cited by this paper
• Characteristics of Symptomatic Reflux Episodes on Acid Suppressive Therapy

  2008cited by this paper
• Role of Acid and Nonacid Reflux in Children With Eosinophilic Esophagitis Compared With Patients With Gastroesophageal Reflux and Control Patients

  2008cited by this paper
• Exam 2: An Analysis of Persistent Symptoms in Acid Suppressed Patients Undergoing Impedance-Ph Monitoring

  2008cited by this paper
• An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring.

  2008cited by this paper
• Persistent heartburn in a patient on proton-pump inhibitor.

  2008cited by this paper
• The influence of co‐morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro‐oesophageal reflux disease

  2008cited by this paper
• Esophageal pH-Impedance Monitoring in Patients With Therapy-Resistant Reflux Symptoms: ‘On’ or ‘Off’ Proton Pump Inhibitor?

  2008cited by this paper
• Yield of 24-Hour Esophageal pH and Bilitec Monitoring in Patients with Persisting Symptoms on PPI Therapy

  2008cited by this paper
• Botulinum Toxin A for the Treatment of Delayed Gastric Emptying

  2008cited by this paper
• Oesophageal tone and sensation in the transition zone between proximal striated and distal smooth muscle oesophagus

  2008cited by this paper
• Pyloric Injection of Botulinum Toxin for the Treatment of Refractory GERD Accompanied with Gastroparesis: A Preliminary Report

  2008cited by this paper
• Esophageal Dilated Intercellular Spaces (DIS) and Nonerosive Reflux Disease

  2008cited by this paper
• Short exposure of oesophageal mucosa to bile acids, both in acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces

  2008cited by this paper
• ACG Practice Guidelines: Esophageal Reflux Testing

  2007cited by this paper
• Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure.

  2007cited by this paper
• Thoughts on the Complex Relationship Between Gastroesophageal Reflux Disease and Eosinophilic Esophagitis

  2007cited by this paper
• Acidity Surrounding the Squamocolumnar Junction in GERD Patients: “Acid Pocket” Versus “Acid Film”

  2007cited by this paper
• Oesophageal hypersensitivity is associated with features of psychiatric disorders and the irritable bowel syndrome

  2007cited by this paper
• Proton pump inhibitor-therapy refractory gastro-oesophageal reflux disease patients, who are they?

  2007cited by this paper
• Circumferential and axial distribution of esophageal mucosal damage in reflux disease.

  2007cited by this paper
• Clinical trial: persistent gastro‐oesophageal reflux symptoms despite standard therapy with proton pump inhibitors – a follow‐up study of intraluminal‐impedance guided therapy

  2007cited by this paper
• Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication

  2007cited by this paper
• How to manage refractory GERD

  2007cited by this paper
• Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus

  2007cited by this paper
• Weakly acidic solutions containing pepsin and bile acids can increase significantly esophageal mucosa permeability

  2007cited by this paper
• Efficacy in intra-oesophageal acid suppression may decrease after 2-year continuous treatment with proton pump inhibitors.

  2007cited by this paper
• Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors

  2007cited by this paper
• Chemosensitivity of the human gastrointestinal tract in health and in disease

  2007cited by this paper
• Biliary reflux and non-acid reflux are two distinct phenomena: A comparison between 24-hour multichannel intraesophageal impedance and bilirubin monitoring

  2007cited by this paper
• Improved diagnosis of gastro‐oesophageal reflux in patients with unexplained chronic cough

  2007cited by this paper
• Esophageal pH-Impedance Monitoring and Symptom Analysis in GERD: A Study in Patients off and on Therapy

  2006cited by this paper
• Rome III: The Functional Gastrointestinal Disorders

  2006cited by this paper
• Gastroesophageal reflux: not a time to "relax".

  2006cited by this paper
• The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus

  2006cited by this paper
• Sub‐optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro‐oesophageal reflux disease

  2006cited by this paper
• Treatment of refractory gastroesophageal reflux disease with radiofrequency energy (Stretta) in patients after Roux-en-Y gastric bypass

  2006cited by this paper
• Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial.

  2006cited by this paper
• Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate.

  2006cited by this paper
• Effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageal reflux disease: a randomized controlled trial.

  2006cited by this paper
• Laparoscopic Antireflux Surgery: Long-Term Outcomes and Quality of Life

  2006cited by this paper
• Comparison of Esophageal Acid Exposure Distribution Along the Esophagus Among the Different Gastroesophageal Reflux Disease (GERD) Groups

  2006cited by this paper
• Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring

  2006cited by this paper
• Combined multichannel intraluminal impedance–pH monitoring to select patients with persistent gastro‐oesophageal reflux for laparoscopic Nissen fundoplication

  2006cited by this paper
• The patient with refractory gastroesophageal reflux disease.

  2006cited by this paper
• Acid-suppressive effects of rabeprazole: comparing 10mg and 20mg twice daily in Japanese Helicobacter pylori-negative and -positive CYP2C19 extensive metabolisers.

  2006cited by this paper
• Functional Heartburn Patients Demonstrate Traits of Functional Bowel Disorder but Lack a Uniform Increase of Chemoreceptor Sensitivity to Acid

  2006cited by this paper
• Dilated Intercellular Spaces: A Major Morphological Feature of Esophagitis

  2006cited by this paper
• Reversibility of GERD Ultrastructural Alterations and Relief of Symptoms After Omeprazole Treatment

  2005cited by this paper
• Dilated Intercellular Spaces of Esophageal Epithelium in Nonerosive Reflux Disease Patients with Physiological Esophageal Acid Exposure

  2005cited by this paper
• Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo)

  2005cited by this paper
• The Value of Ambulatory 24 hr Esophageal pH Monitoring in Clinical Practice in Patients Who Were Referred with Persistent Gastroesophageal Reflux Disease (GERD)-Related Symptoms While on Standard Dose Anti-Reflux Medications

  2005cited by this paper
• Bolus transit patterns in healthy subjects: a study using simultaneous impedance monitoring, videoesophagram, and esophageal manometry.

  2005cited by this paper
• Esophageal Visceral Sensitivity to Bile Salts in Patients with Functional Heartburn and in Healthy Control Subjects

  2005cited by this paper
• The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis.

  2005cited by this paper
• Normalization of oesophageal pH does not guarantee control of duodenogastro‐oesophageal reflux in Barrett's oesophagus

  2005cited by this paper
• The Role of Esophageal pH Monitoring in Symptomatic Patients on PPI Therapy

  2005cited by this paper
• Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy.

  2005cited by this paper
• Is there a set of histologic changes that are invariably reflux associated?

  2005cited by this paper
• Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy.

  2005cited by this paper
• Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach.

  2005cited by this paper
• Reassessment of the Diagnostic Value of Histology in Patients with GERD, Using Multiple Biopsy Sites and an Appropriate Control Group

  2005cited by this paper
• Idiopathic eosinophilic esophagitis in adults: the ringed esophagus.

  2005cited by this paper
• Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease.

  2005cited by this paper
• Direct Comparison of Impedance, Manometry, and pH Probe in Detecting Reflux Before and After a Meal

  2005cited by this paper
• Systematic review: proton‐pump inhibitor failure in gastro‐oesophageal reflux disease – where next?

  2005cited by this paper
• Effectiveness of proton pump inhibitors in nonerosive reflux disease.

  2004cited by this paper
• Acid, weakly acidic and non-acid gastro-oesophageal reflux: differences, prevalence and clinical relevance

  2004cited by this paper
• Review article: gastro‐oesophageal reflux disease as a functional gastrointestinal disorder

  2004cited by this paper
• Complete Elimination of Reflux Symptoms Does not Guarantee Normalization of Intraesophageal and Intragastric pH in Patients with Gastroesophageal Reflux Disease (GERD)

  2004cited by this paper
• Natural history of primary eosinophilic esophagitis: a follow up of 30 adult patients for up to 11.5 years.

  2004cited by this paper
• Eosinophilic esophagitis in adults: an emerging problem with unique esophageal features.

  2004cited by this paper
• The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor.

  2004cited by this paper
• Review article: supra‐oesophageal manifestations of gastro‐oesophageal reflux disease and the role of night‐time gastro‐oesophageal reflux

  2004cited by this paper
• Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux

  2004cited by this paper
• Studies of acid exposure immediately above the gastro-oesophageal squamocolumnar junction: evidence of short segment reflux

  2004cited by this paper
• Gastroesophageal Reflux Disease Poorly Responsive to Single-Dose Proton Pump Inhibitors in Patients without Barrett's Esophagus: Acid Reflux, Bile Reflux, or Both?

  2004cited by this paper
• Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs

  2003cited by this paper
• The efficacy of omeprazole twice daily with supplemental H2 blockade at bedtime in the suppression of nocturnal oesophageal and gastric acidity

  2003cited by this paper
• Baclofen decreases acid and non‐acid post‐prandial gastro‐oesophageal reflux measured by combined multichannel intraluminal impedance and pH

  2003cited by this paper
• Effect of the GABAB agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors

  2003cited by this paper
• Relevance of ineffective oesophageal motility during oesophageal acid clearance

  2003cited by this paper
• Non‐erosive reflux disease (NERD) — acid reflux and symptom patterns

  2003cited by this paper
• Clinical and endoscopic features of eosinophilic esophagitis in adults.

  2003cited by this paper
• Non-Erosive Reflux Disease

  2003cited by this paper
• Non-erosive reflux disease (NERD) — acid reflux and symptom patterns

  2003cited by this paper
• Esophageal volume clearance can be accurately assessed with intraluminal electrical impedance

  2003cited by this paper
• Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years.

  2003cited by this paper
• An evaluation of the clinical implications of acid breakthrough in patients on proton pump inhibitor therapy

  2002cited by this paper
• Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough.

  2002cited by this paper
• Control of transient lower oesophageal sphincter relaxations and reflux by the GABAB agonist baclofen in patients with gastro-oesophageal reflux disease

  2002cited by this paper
• Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis

  2001cited by this paper
• Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole.

  2001cited by this paper
• Gastrointestinal afferents as targets of novel drugs for the treatment of functional bowel disorders and visceral pain.

  2001cited by this paper
• The role of acid and duodenal gastroesophageal reflux in symptomatic GERD

  2001cited by this paper
• Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis

  2001cited by this paper
• Proton pump inhibitors: better acid suppression when taken before a meal than without a meal

  2000cited by this paper

• Is reflux hypersensitivity truly a functional gastrointestinal disorder? A retrospective cross-sectional study

  2025cites this paper
• Recomendaciones de buena práctica clínica para el manejo de la enfermedad por reflujo gastroesofágico. Revisión por expertos latinoamericanos

  2025cites this paper
• Poliprotect®, a Medical Device Made of Substances, Potently Protects the Human Esophageal Mucosa Challenged by Multiple Agents: Evidence from In Vitro and Ex Vivo Electrophysiological Models

  2025cites this paper
• Association between gastric rhythm and gastroesophageal reflux defined by simultaneous body surface gastric mapping and 24-hour pH testing

  2025cites this paper
• Development of a Machine Learning Model to Predict Therapeutic Responses in Laryngopharyngeal Reflux Disease.

  2025cites this paper
• Hyaluronic acid and chondroitin sulfate-based medical devices: formulations, esophageal mucosal protection, and their place in the management of GERD

  2025cites this paper
• Overlap of esophageal disorders of gut-brain interactions (E-DGBIs) and GERD is highly prevalent in patients with refractory reflux symptoms.

  2025cites this paper
• E-Gastryal® + Magnesium Alginate Plus PPI vs. PPI Alone in GERD: Results from the GENYAL® Randomized Controlled Trial

  2025cites this paper
• Successful treatment of refractory gastroesophageal reflux-induced chronic cough with vonoprazan: a report of three cases.

  2025cites this paper
• Potassium-competitive acid blockers.

  2025cites this paper
• Drug treatment strategies for erosive esophagitis in adults: a narrative review

  2025cites this paper
• Predictive factors for neuromodulator response in patients with nonacid gastroesophageal reflux-induced chronic cough: a retrospective data analysis

  2025cites this paper
• Good clinical practice recommendations for the management of gastroesophageal reflux disease. A Latin American expert review.

  2025cites this paper
• Preoperative gastroenterological evaluation for anti-reflux surgery: strengthening surgeon-gastroenterologist collaboration and improving patient selection

  2025cites this paper
• Topical Protection of Esophageal Mucosa as a New Treatment of GERD

  2025cites this paper
• Good clinical practice recommendations for the diagnosis and treatment of gastroesophageal reflux disease. An expert review from the Asociación Mexicana de Gastroenterología.

  2024cites this paper
• Pharmacokinetic Comparison and Bioequivalence Evaluation of Two 20-mg Vonoprazan Fumarate Tablets in Bangladeshi Healthy Male Subjects

  2024cites this paper
• Vonoprazan causes symptomatic improvement in non-erosive gastroesophageal reflux disease: A systematic review and meta-analysis.

  2024cites this paper
• Magnetic sphincter augmentation in the management of gastro-esophageal reflux disease: a systematic review and meta-analysis

  2024cites this paper
• Causal relationship analysis between 35 blood/urine metabolites and gastroesophageal reflux disease: A Mendelian randomization combined meta-analysis study

  2024cites this paper
• Therapy of Upper Gastrointestinal Symptoms: Experience with a Medical Device Made of Natural Substances

  2024cites this paper
• Differences Between Patients with Heartburn Refractory to Vonoprazan and Those Refractory to Proton Pump Inhibitors

  2024cites this paper
• Prevalence of functional esophageal disorders and associated clinical characteristics in patients with proton‐pump‐inhibitor‐unresponsive reflux symptoms

  2024cites this paper
• A scientometrics analysis and visualization of refractory gastroesophageal reflux disease

  2024cites this paper
• Recomendaciones de buena práctica clínica en el diagnóstico y tratamiento de la enfermedad por reflujo gastroesofágico. Revisión por expertos de la Asociación Mexicana de Gastroenterología

  2024cites this paper
• Refractory Gastroesophageal Reflux Disease: Diagnosis and Management

  2024cites this paper
• Pepsin in saliva for the diagnosis of erosive esophagitis post-sleeve gastrectomy: a prospective observational study

  2023cites this paper
• Multicentre prospective study to evaluate effectiveness and safety of gel-forming and hyaluronic-acid containing chewable tablets as add-on treatment in patients with gastroesophageal reflux disease (GERD) symptoms and unsatisfying proton pump inhibitor therapy

  2023cites this paper
• A Meta-Analysis of Proton Pump Inhibitor Use and the Risk of Acute Kidney Injury: Geographical Differences and Associated Factors

  2023cites this paper
• JP‐1366: A novel and potent potassium‐competitive acid blocker that is effective in the treatment of acid‐related diseases

  2023cites this paper
• Longer-term outcomes of gastroesophageal reflux disease treated with magnetic sphincter augmentation

  2023cites this paper
• Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP‐1366), a novel potassium‐competitive acid blocker, in healthy subjects

  2023cites this paper
• Wirelessly powered deformable electronic stent for noninvasive electrical stimulation of lower esophageal sphincter

  2023cites this paper
• Mean Nocturnal Baseline Impedance (MNBI) Provides Evidence for Standardized Management Algorithms of Nonacid Gastroesophageal Reflux-Induced Chronic Cough

  2023cites this paper
• Proton Pump Inhibitors and Risk of Chronic Kidney Disease: Evidence from Observational Studies

  2023cites this paper
• Outcome of Endoscopic Band Ligation in Cases with Gerd Refractory to Once Daily Medical Therapy of Dexlansoprazole

  2023cites this paper
• Neuromodulation for Gastroesophageal Reflux Disease: A Systematic Review.

  2023cites this paper
• Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study

  2023cites this paper
• Acupuncture Improved the Function of the Lower Esophageal Sphincter and Esophageal Motility in Chinese Patients with Refractory Gastroesophageal Reflux Disease Symptoms: A Randomized Trial

  2023cites this paper
• Frequency of functional esophageal disorders in patients with refractory reflux symptoms in Lima, Peru.

  2023cites this paper
• Protective Mechanisms of Liquid Formulations for Gastro-Oesophageal Reflux Disease in a Human Reconstructed Oesophageal Epithelium Model

  2022cites this paper
• Traditional Chinese medicine based on Tongjiang methodology combined with proton pump inhibitor (PPI) step-down in treating non-erosive reflux disease: a study protocol for a multicentered, randomized controlled clinical trial

  2022cites this paper
• The Clinical value of brain‐gut behavioral therapies for functional esophageal disorders and symptoms

  2022cites this paper
• Design, synthesis and biological evaluation of novel 5-methyl-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole derivatives as potent potassium-competitive acid blockers.

  2022cites this paper
• 새로운 칼륨 경쟁적 위산분비 차단제

  2022cites this paper
• Hiatal hernia repair with transoral incisionless fundoplication versus Nissen fundoplication for gastroesophageal reflux disease: A retrospective study

  2022cites this paper
• Long-term vonoprazan therapy is effective for controlling symptomatic proton pump inhibitor-resistant gastroesophageal reflux disease.

  2021cites this paper
• Review article: potassium‐competitive acid blockers for the treatment of acid‐related disorders

  2021cites this paper
• Evaluation and Management of Patients with PPI-Refractory Heartburn

  2021cites this paper
• ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.

  2021cites this paper
• EZH2-mediated suppression of CLDN1 leads to barrier dysfunction in PPI-refractory gastroesophageal reflux disease.

  2021cites this paper
• Vonoprazan for treatment of gastroesophageal reflux disease: Research advances

  2021cites this paper
• Esophageal Nocturnal Baseline Impedance and Post-reflux Swallow-induced Peristaltic Wave Index in Identifying Proton Pump Inhibitor-refractory Non-erosive Reflux Disease

  2021cites this paper
• Refractory Gastroesophageal Reflux Disease: A Management Update

  2021cites this paper
• Consensus statements and recommendations on the management of mild‐to‐moderate gastroesophageal reflux disease in the Southeast Asian region

  2021cites this paper
• Management of Gastroesophageal Reflux Disease: Surgical and Therapeutic Innovations

  2020cites this paper
• ESNM/ANMS consensus paper: Diagnosis and management of refractory gastro‐esophageal reflux disease

  2020cites this paper
• Cost-effectiveness analysis of vonoprazan versus proton pump inhibitors in the treatment of reflux esophagitis in China

  2020cites this paper
• The Role of Salivary Pepsin in the Diagnosis of Gastroesophageal Reflux Disease (GERD) Evaluated Using High-Resolution Manometry and 24-Hour Multichannel Intraluminal Impedance-pH Monitoring

  2020influential citation
• The pharmacotherapeutic management of gastroesophageal reflux disease (GERD)

  2020cites this paper
• The role of interleukin 1β and interleukin 1 receptor antagonist polymorphism genes, Helicobacter pylori infection and the state of the gastric mucosa in the development and progression of gastroesophageal reflux disease

  2020cites this paper
• Risk Factors Associated with Gastro-Esophageal Reflux Disease

  2020cites this paper
• Evaluation and Treatment of Patients with Persistent Reflux Symptoms Despite Proton Pump Inhibitor Treatment.

  2020cites this paper
• IW-3718 Reduces Heartburn Severity in Patients With Refractory Gastroesophageal Reflux Disease in a Randomized Trial.

  2020cites this paper
• Rethinking gastroesophageal reflux disorder

  2020cites this paper
• Endostim Implantation

  2020cites this paper
• Refractory Gastroesophageal Reflux Disease and Functional Heartburn.

  2020cites this paper
• TO STUDY THE RISK FACTORS ASSOCIATED WITH GASTROESOPHAGEAL REFLUX DISEASE

  2020cites this paper
• Understanding gastrointestinal motility studies in pediatrics.

  2020cites this paper
• Novel Therapies for Gastroesophageal Reflux Disease: Beyond Proton Pump Inhibitors

  2020cites this paper
• In search of the grail: A race for acid suppression

  2019cites this paper
• Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn.

  2019cites this paper
• In search of the grail: A race for acid suppression.

  2019cites this paper
• Magnetic sphincter augmentation (MSA) in patients with hiatal hernia: clinical outcome and patterns of recurrence

  2019cites this paper
• Is that ‘floppy’ fundoplication tight enough?

  2019cites this paper
• Oesophageal hypersensitivity in patients with gastro-oesophageal reflux symptoms : prevalence and novel treatments

  2019cites this paper
• Food, Nutrients, and Dietary Supplements in Management of Disorders of Gut–Brain Interaction, Formerly Functional Gastrointestinal Disorders

  2019cites this paper
• How to select patients for antireflux surgery? The ICARUS guidelines (international consensus regarding preoperative examinations and clinical characteristics assessment to select adult patients for antireflux surgery)

  2019cites this paper
• Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux

  2019cites this paper
• In search of the grail : A race for acid suppression

  2019cites this paper
• The Spectrum of Reflux Phenotypes.

  2019cites this paper
• Functional heartburn: An underrecognized cause of PPI-refractory symptoms

  2019cites this paper
• Comparison of surgical payer costs and implication on the healthcare expenses between laparoscopic magnetic sphincter augmentation (MSA) and laparoscopic Nissen fundoplication (LNF) in a large healthcare system

  2019cites this paper
• Genome-wide association study of gastrointestinal disorders reinforces the link between the digestive tract and the nervous system

  2019cites this paper
• A reduced esophageal epithelial integrity in a subgroup of healthy individuals increases with proton pump inhibitor therapy

  2018cites this paper
• Gastrointestinal Motility Disorders

  2018influential citation
• The Proton Pump Inhibitor Nonresponder: a Behavioral Approach to Improvement and Wellness

  2018cites this paper
• Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions

  2018influential citation
• Gastroesophageal Reflux Disease Might Induce Certain—Supposedly Adaptive—Changes in the Esophagus: A Hypothesis

  2018cites this paper
• Study on the Therapeutic Effects of Drug and Cognitive-Behavioral Therapy on Non-Erosive Reflux Disease Patients With Emotional Disorders

  2018cites this paper
• The Rome IV versus Rome III criteria for heartburn diagnosis: A comparative study

  2018cites this paper
• Current and future perspectives in the management of gastroesophageal reflux disease

  2018cites this paper
• Adding Acotiamide to Gastric Acid Inhibitors Is Effective for Treating Refractory Symptoms in Patients with Non-erosive Reflux Disease

  2018cites this paper
• PROLONGED GASTROESOPHAGEAL REFLUX MONITORING BY IMPEDANCE-PHMETRY: A REVIEW OF THE SUBJECT PONDERED WITH OUR EXPERIENCE WITH 1,200 CASES.

  2018cites this paper
• Tegoprazan, a Novel Potassium-Competitive Acid Blocker to Control Gastric Acid Secretion and Motility

  2018cites this paper
• Ночная изжога – выход есть

  2018cites this paper
• Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: a double-blind, randomized, placebo-controlled clinical trial.

  2018cites this paper
• Reflux Aspiration and Lung Disease

  2018cites this paper
• Endoscopic management of refractory gastroesophageal reflux disease

  2018cites this paper
• Nonerosive Reflux Disease (NERD)

  2018cites this paper